Firstly, BNP has a lytic effect in adipose tissue (35, 36) and dyslipidemia may lead to vascular endothelial damage, increasing the release of neutral endopeptidases, thereby accelerating BNP degradation. This evidence concerns the gene MME and metabolic syndrome.